BIOQUAL
9600 Medical Center Drive
Rockville
Maryland
20850
United States
Tel: 301-251-2801
Fax: 301-251-1260
Website: http://www.bioqual.com/
46 articles about BIOQUAL
-
BIOQUAL Declares Dividend - September 22, 2023
9/22/2023
BIOQUAL’s Board of Directors has declared a dividend of $0.50 per share for shareholders of record on October 6, 2023, payable on October 27, 2023.
-
BIOQUAL Presents Financial Results for Fiscal Year 2023
9/20/2023
Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties.
-
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2023
1/20/2023
For more detail related to the fiscal year 2023 unaudited second quarter results, please visit our web site.
-
BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2023
10/21/2022
For more detail related to the fiscal year 2023 unaudited first quarter results, please visit BIOQUAL website.
-
BIOQUAL, Inc. Announces New CFO
10/6/2022
BIOQUAL, Inc., Announces Promotion of Mr. Charles C. Kirk, Jr., CPA. to the Position of Chief Financial Officer.
-
BIOQUAL Declares Dividend
9/27/2022
BIOQUAL’s Board of Directors has declared a dividend of $1.00 per share for shareholders of record on October 6, 2022, payable on October 27, 2022.
-
BIOQUAL Presents Financial Results for Fiscal Year 2022
9/19/2022
BIOQUAL Presents Financial Results for Fiscal Year 2022.
-
BIOQUAL, Inc. CFO Announces Retirement and Appointment to BIOQUAL Board
5/9/2022
BIOQUAL, Inc., announced that Dave Newcomer will retire from his role as Chief Financial Officer effective June 3, 2022.
-
BIOQUAL, Inc. Announces Creation of the Role of Chief Scientific Officer
5/9/2022
BIOQUAL, Inc., Announces Creation of the Role of Chief Scientific Officer and Appointment of Hanne Andersen Elyard, PhD, As the Initial Chief Scientific Officer.
-
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2022
1/21/2022
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2022.
-
BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2022
10/22/2021
BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2022
-
BIOQUAL Presents Financial Results for Fiscal Year 2021 and Declares Dividend
9/17/2021
BIOQUAL, Inc. has declared a dividend of $1.25 per share for shareholders of record on September 29, 2021, payable on October 20, 2021.
-
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2021
4/21/2021
BIOQUAL, Inc. announced details to the fiscal year 2021 unaudited third quarter results
-
John C. Landon, Founder of BIOQUAL, Inc., Passes Away at the Age Of 84
1/22/2021
Dr. John C. Landon, past president, CEO and former chairman of the board of BIOQUAL, passed away Sunday, January 10, 2021, at the age of 84. John was born and raised in Hornell, New York, and went on to earn a B.A. degree in biology from Alfred College (class of 1959) and M.S. and Ph.D. degrees in biology from The George Washington University in 1962 and 1967,
-
BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2021
10/21/2020
BIOQUAL, Inc. (OTC Pink: BIOQ) ( www.bioqual.com ): Three Months Ended August 31, 2020 2019 Revenue $ 14,920,475 $ 10,067,876 Income Before Income
-
BIOQUAL Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of an mRNA Vaccine Against COVID-19 (mRNA-1273)
8/10/2020
BIOQUAL announces the publication of the successful testing of an mRNA vaccine in non-human primates.
-
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2020
4/21/2020
For more detail related to the fiscal year 2020 unaudited second quarter results, please visit our web site at www.bioqual.com.
-
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2020
1/21/2020
Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties.
-
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2019
4/16/2019
Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties.
-
Death of J. Thomas August, MD, a Member of the Board of Directors of BIOQUAL, Inc.
2/22/2019
On February 11, 2019, J. Thomas August, MD, a director of BIOQUAL, Inc., since 1982, passed away at the age of 91.